Biocept to Present at the LD Micro Main Event on October 13

Rhea-AI Summary

Biocept, Inc (Nasdaq: BIOC) will present a company overview at the LD Micro Main Event on October 13, 2021, at 11:00 a.m. PT in Los Angeles. This presentation will be led by Michael Nall, President and CEO. A pre-recorded webcast will be accessible on the company's Events and Presentations webpage starting at the same time as the presentation. Biocept specializes in molecular diagnostic assays for cancer detection and monitoring, and also offers RT-PCR-based COVID-19 testing.

SAN DIEGO--(BUSINESS WIRE)-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will present a company overview at the LD Micro Main Event on Wednesday, October 13, 2021 at 11:00 a.m. Pacific time (2:00 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

A pre-recorded webcast of the presentation will be available on the Events and Presentations page of the company website beginning October 13 at 11:00 a.m. Pacific time.

About Biocept

Biocept, Inc., develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information to aid in the diagnosis, treatment and monitoring of patients with cancer. In addition to its broad portfolio of blood-based liquid biopsy tests, the company has developed the CNSide^TM cerebrospinal fluid assay, designed to diagnose cancer that has metastasized to the central nervous system. Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide RT-PCR-based COVID-19 testing and services to support public health efforts during this unprecedented pandemic. For more information, visit www.biocept.com. Follow Biocept on Facebook, LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211006005352/en/

Investors

Jody Cain, LHA Investor Relations

Jcain@lhai.com, 310-691-7100

Media

Andrea Sampson, Sampson PR Group

asampson@sampsonprgroup.com, 562-304-0301

Source: Biocept, Inc.

FAQ

When will Biocept present at the LD Micro Main Event?

Biocept will present on October 13, 2021, at 11:00 a.m. Pacific time.

Who is presenting on behalf of Biocept at the LD Micro Main Event?

Michael Nall, President and CEO, will present on behalf of Biocept.

Where is the LD Micro Main Event being held?

The LD Micro Main Event is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

How can I access Biocept's presentation after it airs?

A pre-recorded webcast of the presentation will be available on Biocept's Events and Presentations webpage.

What does Biocept specialize in?

Biocept specializes in molecular diagnostic assays for cancer detection and also offers COVID-19 testing services.